Details for 2018768948
Up to date per 18.05.2026
Actions
Details for 2018768948
Granted/Registered
European Patent
01.07.2020 A
08.11.2023 B1
24.08.2017
US
201762549732 P
07.12.2017
EP
17306720
A61K 38/46 20060101AFI20200330BHEP
Owner
Genzyme Corporation450 Water Street Cambridge, MA 02141US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
SCHEIDT-PUGA, Ana Cristinac/o Sanofi Département Brevets 54 Rue La Boétie 75008 ParisFR
Information about Fees